212 related articles for article (PubMed ID: 37501071)
1. Development of a robust induced pluripotent stem cell atrial cardiomyocyte differentiation protocol to model atrial arrhythmia.
Thorpe J; Perry MD; Contreras O; Hurley E; Parker G; Harvey RP; Hill AP; Vandenberg JI
Stem Cell Res Ther; 2023 Jul; 14(1):183. PubMed ID: 37501071
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
Seibertz F; Rubio T; Springer R; Popp F; Ritter M; Liutkute A; Bartelt L; Stelzer L; Haghighi F; Pietras J; Windel H; Pedrosa NDI; Rapedius M; Doering Y; Solano R; Hindmarsh R; Shi R; Tiburcy M; Bruegmann T; Kutschka I; Streckfuss-Bömeke K; Kensah G; Cyganek L; Zimmermann WH; Voigt N
Cardiovasc Res; 2023 Dec; 119(16):2623-2637. PubMed ID: 37677054
[TBL] [Abstract][Full Text] [Related]
3. Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome.
Shiti A; Arbil G; Shaheen N; Huber I; Setter N; Gepstein L
J Mol Cell Cardiol; 2023 Oct; 183():42-53. PubMed ID: 37579942
[TBL] [Abstract][Full Text] [Related]
4. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
[TBL] [Abstract][Full Text] [Related]
5. [Availability of a novel cardiotoxicity evaluation system using human induced pluripotent stem cell-derived atrial-like myocytes].
Honda Y
Nihon Yakurigaku Zasshi; 2020; 155(5):303-308. PubMed ID: 32879170
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
[TBL] [Abstract][Full Text] [Related]
7. A critical role of retinoic acid concentration for the induction of a fully human-like atrial action potential phenotype in hiPSC-CM.
Schulz C; Sönmez M; Krause J; Schwedhelm E; Bangfen P; Alihodzic D; Hansen A; Eschenhagen T; Christ T
Stem Cell Reports; 2023 Nov; 18(11):2096-2107. PubMed ID: 37922915
[TBL] [Abstract][Full Text] [Related]
8.
Schulz C; Lemoine MD; Mearini G; Koivumäki J; Sani J; Schwedhelm E; Kirchhof P; Ghalawinji A; Stoll M; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011602. PubMed ID: 36763906
[TBL] [Abstract][Full Text] [Related]
9. A 3-D human model of complex cardiac arrhythmias.
Williams K; Liang T; Massé S; Khan S; Hatkar R; Keller G; Nanthakumar K; Nunes SS
Acta Biomater; 2021 Sep; 132():149-161. PubMed ID: 33713861
[TBL] [Abstract][Full Text] [Related]
10. Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes.
Benzoni P; Campostrini G; Landi S; Bertini V; Marchina E; Iascone M; Ahlberg G; Olesen MS; Crescini E; Mora C; Bisleri G; Muneretto C; Ronca R; Presta M; Poliani PL; Piovani G; Verardi R; Di Pasquale E; Consiglio A; Raya A; Torre E; Lodrini AM; Milanesi R; Rocchetti M; Baruscotti M; DiFrancesco D; Memo M; Barbuti A; Dell'Era P
Cardiovasc Res; 2020 May; 116(6):1147-1160. PubMed ID: 31504264
[TBL] [Abstract][Full Text] [Related]
11. Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity.
Liu J; Volkers L; Jangsangthong W; Bart CI; Engels MC; Zhou G; Schalij MJ; Ypey DL; Pijnappels DA; de Vries AAF
Cardiovasc Res; 2018 Dec; 114(14):1848-1859. PubMed ID: 29917042
[TBL] [Abstract][Full Text] [Related]
12. Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation.
Ghazizadeh Z; Kiviniemi T; Olafsson S; Plotnick D; Beerens ME; Zhang K; Gillon L; Steinbaugh MJ; Barrera V; Sui SH; Werdich AA; Kapur S; Eranti A; Gunn J; Jalkanen J; Airaksinen J; Kleber AG; Hollmén M; MacRae CA
Circulation; 2020 Jan; 141(4):301-312. PubMed ID: 31735076
[TBL] [Abstract][Full Text] [Related]
13. Generation of cardiomyocytes from human-induced pluripotent stem cells resembling atrial cells with ability to respond to adrenoceptor agonists.
Ahmad FS; Jin Y; Grassam-Rowe A; Zhou Y; Yuan M; Fan X; Zhou R; Mu-U-Min R; O'Shea C; Ibrahim AM; Hyder W; Aguib Y; Yacoub M; Pavlovic D; Zhang Y; Tan X; Lei M; Terrar DA
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220312. PubMed ID: 37122218
[TBL] [Abstract][Full Text] [Related]
14. Biophysical properties of Na
Chapotte-Baldacci CA; Pierre M; Djemai M; Pouliot V; Chahine M
Sci Rep; 2023 Nov; 13(1):20685. PubMed ID: 38001331
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte functional screening: interrogating comparative electrophysiology of high-throughput model cell systems.
Wells SP; Waddell HM; Sim CB; Lim SY; Bernasochi GB; Pavlovic D; Kirchhof P; Porrello ER; Delbridge LMD; Bell JR
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1256-C1267. PubMed ID: 31577512
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes.
Biendarra-Tiegs SM; Li X; Ye D; Brandt EB; Ackerman MJ; Nelson TJ
Stem Cells Dev; 2019 May; 28(10):659-673. PubMed ID: 30892143
[TBL] [Abstract][Full Text] [Related]
17. Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells.
Bett GC; Kaplan AD; Lis A; Cimato TR; Tzanakakis ES; Zhou Q; Morales MJ; Rasmusson RL
Heart Rhythm; 2013 Dec; 10(12):1903-10. PubMed ID: 24055949
[TBL] [Abstract][Full Text] [Related]
18. Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation.
Ly OT; Brown GE; Han YD; Darbar D; Khetani SR
Exp Biol Med (Maywood); 2021 Aug; 246(16):1816-1828. PubMed ID: 33899540
[TBL] [Abstract][Full Text] [Related]
19. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
Devalla HD; Schwach V; Ford JW; Milnes JT; El-Haou S; Jackson C; Gkatzis K; Elliott DA; Chuva de Sousa Lopes SM; Mummery CL; Verkerk AO; Passier R
EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
[TBL] [Abstract][Full Text] [Related]
20. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
